Manas Jaiswal of manasjaiswal.com has a buy call on Biocon Ltd.
with a target price of Rs 658.
The current market price of Biocon Ltd.
is Rs 640.9.
Time period given by analyst is Intra Day when Biocon Ltd.
price can reach defined target.
Manas Jaiswal recommended to keep stoploss at Rs 634.
Biocon Ltd., incorporated in 1978, is a largecap company with a market cap of Rs 38454.00 crore.
Biocon Ltd.
key Products/Revenue Segments include Bio Pharmaceuticals which contributed Rs 2211.10 Crore to Sales Value (91.16 % of Total Sales), Other Operating Revenue which contributed Rs 197.70 Crore to Sales Value (8.15 % of Total Sales), Waste which contributed Rs 12.50 Crore to Sales Value (0.51 % of Total Sales) and Sale of services which contributed Rs 4.20 Crore to Sales Value (0.17 % of Total Sales)for year ending 31-Mar-2018.
For quarter ended 30-09-2018, company has reported a Consolidated sales of Rs 1321.00 Crore, up 17.55 % from last quarter Sales of Rs 1123.80 Crore and up 36.38 % from last year same quarter Sales of Rs 968.60 Crore Company has reported net profit after tax of Rs 378.60 Crore in latest quarter.
The companys top management includes Dr.Arun Chandavarkar, Dr.Jeremy Levin, Dr.Vijay Kuchroo, Mr.Bobby Kanubhai Parikh, Mr.Daniel M Bradbury, Mr.John Shaw, Mr.Kiran Mazumdar Shaw, Mr.M Damodaran, Mr.Mary Harney, Mr.Russel Walls, Prof.Ravi Mazumdar.
Company has B S R Co.
LLP as its auditoRs As on 30-09-2018, company has a total of 600,000,000 shares outstanding.